Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
10 Apr 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
28 Mar 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Apr 24
8-K
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
1 Apr 24
8-K
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
25 Mar 24
8-K
Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
27 Feb 24
8-K
Departure of Directors or Certain Officers
14 Feb 24
8-K
Venus Concept Inc. Announces Review of Strategic Alternatives
24 Jan 24
8-K
Venus Concept Inc. Announces Issuance of $2.0M of Convertible Notes
19 Jan 24
8-K
Other Events
15 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1 Dec 23
8-K
Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
14 Nov 23
Registration and prospectus
S-3
Shelf registration
8 Apr 24
S-1
IPO registration
3 Apr 24
D
$1.10 mm in options / securities to be acquired, sold $1.10 mm, 2 investors
7 Mar 24
424B5
Prospectus supplement for primary offering
26 Feb 24
S-3
Shelf registration
1 Dec 23
S-3/A
Shelf registration (amended)
22 Nov 23
S-3
Shelf registration
14 Jul 23
S-8
Registration of securities for employees
26 May 23
D
$9.00 mm in equity / options, sold $2.00 mm, 2 investors
24 May 23
S-3
Shelf registration
19 Dec 22
Proxies
DEF 14A
Definitive proxy
10 Apr 23
PRE 14A
Preliminary proxy
20 Mar 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
DEF 14A
Definitive proxy
28 Apr 20
PRE 14A
Preliminary proxy
16 Apr 20
DEFA14A
Additional proxy soliciting materials
26 Apr 18
Other
EFFECT
Notice of effectiveness
18 Apr 24
EFFECT
Notice of effectiveness
21 Dec 23
EFFECT
Notice of effectiveness
21 Dec 23
CORRESP
Correspondence with SEC
18 Dec 23
CORRESP
Correspondence with SEC
18 Dec 23
UPLOAD
Letter from SEC
12 Dec 23
SD
Conflict minerals disclosure
31 May 23
EFFECT
Notice of effectiveness
27 Dec 22
CORRESP
Correspondence with SEC
20 Dec 22
UPLOAD
Letter from SEC
20 Dec 22
Ownership
SC 13G
INTRACOASTAL CAPITAL, LLC
1 Mar 24
SC 13D/A
MASTERS CAPITAL MANAGEMENT LLC
29 Feb 24
SC 13D/A
EW Healthcare Partners, L.P.
28 Feb 24
SC 13D/A
Madryn Asset Management, LP
22 Feb 24
SC 13D/A
EW Healthcare Partners, L.P.
22 Jan 24
4
Change in insider ownership
19 Jan 24
SC 13D/A
EW Healthcare Partners, L.P.
23 Oct 23
4
Change in insider ownership
20 Oct 23
SC 13D/A
Madryn Asset Management, LP
12 Oct 23
4
Change in insider ownership
6 Oct 23